<p>随着全球市场在消费者通胀上升和企业盈利强劲的背景下航行，像标准普尔 500 指数和纳斯达克综合指数这样的指数达到了新高，反映了投资者的乐观情绪。在这种背景下，内部持股比例高的成长型公司尤其引人注目；它们在创新潜力和内部人士与股东之间的利益一致性方面可以为当今市场环境提供独特的机会。</p>
<h3>全球内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>盈利增长</strong></td>
</tr>
<tr>
<td>浙江零跑科技 (SEHK:9863)</td>
<td>15.6%</td>
<td>61%</td>
</tr>
<tr>
<td>上海华测导航技术 (SZSE:300627)</td>
<td>24.3%</td>
<td>23.5%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>28.2%</td>
</tr>
<tr>
<td>M31 科技 (TPEX:6643)</td>
<td>30.8%</td>
<td>63.4%</td>
</tr>
<tr>
<td>老普金 (SEHK:6181)</td>
<td>35.5%</td>
<td>42.6%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>38.3%</td>
<td>94.5%</td>
</tr>
<tr>
<td>金电路电子 (TWSE:2368)</td>
<td>31.4%</td>
<td>25.9%</td>
</tr>
<tr>
<td>富林精密 (SZSE:300432)</td>
<td>13.6%</td>
<td>43.7%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>24.4%</td>
<td>79%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们快速增长的全球内部持股比例高的 813 只股票的完整列表。</p>
<p>让我们从我们的专业筛选器中发现一些宝藏。</p>
<h2>润本股份 (SHSE:603193)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 润本股份有限公司专注于蚊虫驱避产品、婴儿护理产品和精油产品的研究、生产和销售，市值为 119.9 亿人民币。</p>
<p><strong>运营：</strong> 公司的收入主要来自个人护理产品部门，总计为 13.9 亿人民币。</p>
<p><strong>内部持股比例：</strong> 29.2%</p>
<p><strong>收入增长预测：</strong> 年均 24.2%。</p>
<p>润本股份的收入增长强劲，预计年均增长 24.2%，超过中国市场平均水平。尽管市盈率高达 42.7 倍，但仍低于行业平均水平。预计未来三年盈利将显著增长，年均增长 24.33%，超出市场预期。最近的第一季度业绩显示强劲表现，销售额达到 2.4003 亿人民币，净收入从去年的 4420 万人民币增加至 4420 万人民币。</p>
<ul>
<li>点击这里了解润本股份的细微差别，查看我们的详细分析未来增长报告。</li>
<li>我们的润本股份估值报告中的分析暗示其股价相较于估计价值被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41571584-04fe-437d-8261-8c6c369a4bae/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41571584-04fe-437d-8261-8c6c369a4bae/chart/ownership-breakdown"/></p>
<p>截至 2025 年 7 月的 SHSE:603193 持股结构</p>
<h2>上海华测导航技术 (SZSE:300627)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 上海华测导航技术有限公司在导航技术领域运营，市值为 277 亿人民币。</p>
<p><strong>运营：</strong> 上海华测导航技术有限公司的收入来自其导航技术领域的运营。</p>
<p><strong>内部持股比例：</strong> 24.3%</p>
<p><strong>收入增长预测：</strong> 年均 24.5%。</p>
<p>上海华测导航技术有望实现显著增长，预计未来三年盈利将年均增长 23.5%，超过中国市场。收入也预计年均增长 24.5%，超出市场平均水平。公司最近的第一季度业绩显示强劲表现，销售额上升至 7.8912 亿人民币，净收入达到 1.4274 亿人民币，反映出强劲的运营势头，尽管市盈率低于行业平均水平，为 44.8 倍。</p>
<ul>
<li>点击这里访问我们的完整增长分析报告，以了解上海华测导航技术的动态。</li>
<li>我们精心准备的上海华测导航技术估值报告暗示其股价可能过高。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dfee584a-1911-4802-88a1-e9a681c151fe/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dfee584a-1911-4802-88a1-e9a681c151fe/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 7 月的 SZSE:300627 盈利和收入增长</p>
<h2>ASE 科技控股 (TWSE:3711)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> ASE 科技控股有限公司及其子公司提供半导体制造服务，包括组装和测试，覆盖美国、台湾、欧洲、亚洲及全球，市值约为 6562.5 亿新台币。</p>
<p><strong>运营：</strong> 公司的收入部门包括测试 58.94 亿新台币、包装 276.77 亿新台币和电子组装部门 310.28 亿新台币。</p>
<p><strong>内部持股比例：</strong> 28.5%</p>
<p><strong>收入增长预测：</strong> 年均 10.9%。</p>
<p>ASE 科技控股显示出增长潜力，预计未来三年盈利将年均增长 24.9%，超过台湾市场。最近的收入数据显示出积极趋势，第二季度净收入达到 1507.5 亿新台币，较去年 1402.4 亿新台币有所增长。然而，其 3.45% 的股息收益率未能很好地覆盖自由现金流，且股票交易价格显著低于估计的公允价值，尽管预计的股本回报率较低，仅为 16.1%。</p>
<ul>
<li>在我们的盈利增长报告中更深入地了解 ASE 科技控股的潜力。</li>
<li>我们精心准备的 ASE 科技控股估值报告暗示其股价可能低于预期。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/5e85c188-9c9b-4f8e-8f7f-6f7a9a1226f0/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/5e85c188-9c9b-4f8e-8f7f-6f7a9a1226f0/chart/ownership-breakdown"/></p>
<p>截至 2025 年 7 月的 TWSE:3711 持股结构</p>
<h2>将想法转化为行动</h2>
<ul>
<li>点击这里深入了解 813 家快速增长的全球内部持股比例高的公司的宇宙。</li>
<li>寻找新视角？人工智能即将改变医疗保健。这 26 只股票正在从早期诊断到药物发现等各个方面进行工作。最重要的是——它们的市值都在 100 亿美元以下——仍然有机会提前布局。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们仅基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不意图作为财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和盈利增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>

润本股份

零跑汽车

<p>随着全球市场面临消费者通胀上升和强劲的企业盈利，标普 500 指数和纳斯达克综合指数已达到新高。内部持股比例高的成长型公司因其创新潜力和利益一致性而备受关注。前十家公司包括浙江零跑科技、上海华测导航技术和润本股份，均显示出良好的收入增长预测。然而，一些公司，如 ASE Technology Holding，面临股息覆盖和股票估值的挑战。本分析突显了当前市场环境中的机会</p>

<p>As global markets navigate a landscape of rising consumer inflation and robust corporate earnings, indices like the S&amp;P 500 and Nasdaq Composite have reached new highs, reflecting investor optimism. Amidst this backdrop, growth companies with high insider ownership are particularly intriguing; their potential for innovation and alignment of interests between insiders and shareholders can offer unique opportunities in today's market environment.</p>
<div class="lb-trans"><p>随着全球市场在消费者通胀上升和企业盈利强劲的背景下航行，像标准普尔 500 指数和纳斯达克综合指数这样的指数达到了新高，反映了投资者的乐观情绪。在这种背景下，内部持股比例高的成长型公司尤其引人注目；它们在创新潜力和内部人士与股东之间的利益一致性方面可以为当今市场环境提供独特的机会。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership Globally</h3>
<div class="lb-trans"><h3>全球内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Zhejiang Leapmotor Technology (SEHK:9863)</td>
<td>15.6%</td>
<td>61%</td>
</tr>
<tr>
<td>Shanghai Huace Navigation Technology (SZSE:300627)</td>
<td>24.3%</td>
<td>23.5%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>28.2%</td>
</tr>
<tr>
<td>M31 Technology (TPEX:6643)</td>
<td>30.8%</td>
<td>63.4%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>42.6%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>38.3%</td>
<td>94.5%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>25.9%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>13.6%</td>
<td>43.7%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>24.4%</td>
<td>79%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>盈利增长</strong></td>
</tr>
<tr>
<td>浙江零跑科技 (SEHK:9863)</td>
<td>15.6%</td>
<td>61%</td>
</tr>
<tr>
<td>上海华测导航技术 (SZSE:300627)</td>
<td>24.3%</td>
<td>23.5%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.3%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>28.2%</td>
</tr>
<tr>
<td>M31 科技 (TPEX:6643)</td>
<td>30.8%</td>
<td>63.4%</td>
</tr>
<tr>
<td>老普金 (SEHK:6181)</td>
<td>35.5%</td>
<td>42.6%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>38.3%</td>
<td>94.5%</td>
</tr>
<tr>
<td>金电路电子 (TWSE:2368)</td>
<td>31.4%</td>
<td>25.9%</td>
</tr>
<tr>
<td>富林精密 (SZSE:300432)</td>
<td>13.6%</td>
<td>43.7%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>24.4%</td>
<td>79%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 813 stocks from our Fast Growing Global Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们快速增长的全球内部持股比例高的 813 只股票的完整列表。</p>
</div><p>Let's uncover some gems from our specialized screener.</p>
<div class="lb-trans"><p>让我们从我们的专业筛选器中发现一些宝藏。</p>
</div><h2>Runben Biotechnology (SHSE:603193)</h2>
<div class="lb-trans"><h2>润本股份 (SHSE:603193)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Runben Biotechnology Co., Ltd. focuses on the research, production, and sale of mosquito repellent products, baby care products, and essential oil products, with a market cap of CN¥11.99 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 润本股份有限公司专注于蚊虫驱避产品、婴儿护理产品和精油产品的研究、生产和销售，市值为 119.9 亿人民币。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its personal products segment, totaling CN¥1.39 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自个人护理产品部门，总计为 13.9 亿人民币。</p>
</div><p><strong>Insider Ownership:</strong> 29.2%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 29.2%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 24.2% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 年均 24.2%。</p>
</div><p>Runben Biotechnology is experiencing robust revenue growth, forecasted at 24.2% annually, surpassing the CN market average. Despite a high Price-To-Earnings ratio of 42.7x, it remains below the industry average. Earnings are expected to grow significantly at 24.33% per year over the next three years, outpacing market expectations. Recent Q1 results showed strong performance with sales reaching CNY 240.03 million and net income increasing to CNY 44.2 million from last year’s figures.</p>
<div class="lb-trans"><p>润本股份的收入增长强劲，预计年均增长 24.2%，超过中国市场平均水平。尽管市盈率高达 42.7 倍，但仍低于行业平均水平。预计未来三年盈利将显著增长，年均增长 24.33%，超出市场预期。最近的第一季度业绩显示强劲表现，销售额达到 2.4003 亿人民币，净收入从去年的 4420 万人民币增加至 4420 万人民币。</p>
</div><ul>
<li>Click here to discover the nuances of Runben Biotechnology with our detailed analytical future growth report.</li>
<li>The analysis detailed in our Runben Biotechnology valuation report hints at an inflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里了解润本股份的细微差别，查看我们的详细分析未来增长报告。</li>
<li>我们的润本股份估值报告中的分析暗示其股价相较于估计价值被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41571584-04fe-437d-8261-8c6c369a4bae/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/41571584-04fe-437d-8261-8c6c369a4bae/chart/ownership-breakdown"/></p>
<p>SHSE:603193 Ownership Breakdown as at Jul 2025</p>
<div class="lb-trans"><p>截至 2025 年 7 月的 SHSE:603193 持股结构</p>
</div><h2>Shanghai Huace Navigation Technology (SZSE:300627)</h2>
<div class="lb-trans"><h2>上海华测导航技术 (SZSE:300627)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Shanghai Huace Navigation Technology Ltd. operates in the field of navigation technology and has a market capitalization of CN¥27.70 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 上海华测导航技术有限公司在导航技术领域运营，市值为 277 亿人民币。</p>
</div><p><strong>Operations:</strong> Shanghai Huace Navigation Technology Ltd. generates revenue from its operations in the navigation technology sector.</p>
<div class="lb-trans"><p><strong>运营：</strong> 上海华测导航技术有限公司的收入来自其导航技术领域的运营。</p>
</div><p><strong>Insider Ownership:</strong> 24.3%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 24.3%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 24.5% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 年均 24.5%。</p>
</div><p>Shanghai Huace Navigation Technology is poised for significant growth, with earnings expected to increase by 23.5% annually over the next three years, outpacing the CN market. Revenue is also forecasted to grow at 24.5% per year, surpassing market averages. The company's recent Q1 results showed strong performance with sales rising to CNY 789.12 million and net income reaching CNY 142.74 million from last year’s figures, reflecting robust operational momentum despite a lower-than-industry-average Price-To-Earnings ratio of 44.8x.</p>
<div class="lb-trans"><p>上海华测导航技术有望实现显著增长，预计未来三年盈利将年均增长 23.5%，超过中国市场。收入也预计年均增长 24.5%，超出市场平均水平。公司最近的第一季度业绩显示强劲表现，销售额上升至 7.8912 亿人民币，净收入达到 1.4274 亿人民币，反映出强劲的运营势头，尽管市盈率低于行业平均水平，为 44.8 倍。</p>
</div><ul>
<li>Click here and access our complete growth analysis report to understand the dynamics of Shanghai Huace Navigation Technology.</li>
<li>Our expertly prepared valuation report Shanghai Huace Navigation Technology implies its share price may be too high.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们的完整增长分析报告，以了解上海华测导航技术的动态。</li>
<li>我们精心准备的上海华测导航技术估值报告暗示其股价可能过高。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dfee584a-1911-4802-88a1-e9a681c151fe/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/dfee584a-1911-4802-88a1-e9a681c151fe/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300627 Earnings and Revenue Growth as at Jul 2025</p>
<div class="lb-trans"><p>截至 2025 年 7 月的 SZSE:300627 盈利和收入增长</p>
</div><h2>ASE Technology Holding (TWSE:3711)</h2>
<div class="lb-trans"><h2>ASE 科技控股 (TWSE:3711)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> ASE Technology Holding Co., Ltd. and its subsidiaries offer semiconductor manufacturing services, including assembly and testing, across the United States, Taiwan, Europe, Asia, and globally with a market cap of approximately NT$656.25 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> ASE 科技控股有限公司及其子公司提供半导体制造服务，包括组装和测试，覆盖美国、台湾、欧洲、亚洲及全球，市值约为 6562.5 亿新台币。</p>
</div><p><strong>Operations:</strong> The company's revenue segments include NT$58.94 billion from Testing, NT$276.77 billion from Packaging, and NT$310.28 billion from the Electronic Assembly Segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入部门包括测试 58.94 亿新台币、包装 276.77 亿新台币和电子组装部门 310.28 亿新台币。</p>
</div><p><strong>Insider Ownership:</strong> 28.5%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 28.5%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 10.9% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 年均 10.9%。</p>
</div><p>ASE Technology Holding shows potential for growth with earnings projected to increase by 24.9% annually over the next three years, outpacing the TW market. Recent revenue figures highlight a positive trend, with Q2 net revenues reaching TWD 150.75 billion compared to TWD 140.24 billion last year. However, its dividend yield of 3.45% is not well covered by free cash flows, and the stock trades significantly below estimated fair value despite low forecasted return on equity at 16.1%.</p>
<div class="lb-trans"><p>ASE 科技控股显示出增长潜力，预计未来三年盈利将年均增长 24.9%，超过台湾市场。最近的收入数据显示出积极趋势，第二季度净收入达到 1507.5 亿新台币，较去年 1402.4 亿新台币有所增长。然而，其 3.45% 的股息收益率未能很好地覆盖自由现金流，且股票交易价格显著低于估计的公允价值，尽管预计的股本回报率较低，仅为 16.1%。</p>
</div><ul>
<li>Take a closer look at ASE Technology Holding's potential here in our earnings growth report.</li>
<li>Our expertly prepared valuation report ASE Technology Holding implies its share price may be lower than expected.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的盈利增长报告中更深入地了解 ASE 科技控股的潜力。</li>
<li>我们精心准备的 ASE 科技控股估值报告暗示其股价可能低于预期。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/5e85c188-9c9b-4f8e-8f7f-6f7a9a1226f0/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/5e85c188-9c9b-4f8e-8f7f-6f7a9a1226f0/chart/ownership-breakdown"/></p>
<p>TWSE:3711 Ownership Breakdown as at Jul 2025</p>
<div class="lb-trans"><p>截至 2025 年 7 月的 TWSE:3711 持股结构</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>将想法转化为行动</h2>
</div><ul>
<li>Gain an insight into the universe of 813 Fast Growing Global Companies With High Insider Ownership by clicking here.</li>
<li>Searching for a Fresh Perspective? AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里深入了解 813 家快速增长的全球内部持股比例高的公司的宇宙。</li>
<li>寻找新视角？人工智能即将改变医疗保健。这 26 只股票正在从早期诊断到药物发现等各个方面进行工作。最重要的是——它们的市值都在 100 亿美元以下——仍然有机会提前布局。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们仅基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不意图作为财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和盈利增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div>

值得关注的全球增长型公司：高内部持股公司